Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases

Clinical trial NCT07022197 · RECRUITING

Trial details

NCT number: NCT07022197
Sponsor: Tianjin Medical University General Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Inflammatory Demyelinating Polyradiculoneuropathy NMO Spectrum Disorder Myasthenia Gravis Idiopathic Inflammatory Myopathies

Start date: 2025-04-10
Primary completion: 2027-12-30
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.